Listing 1 - 2 of 2 |
Sort by
|
Choose an application
The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgetsTaking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on the efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers.
Pharmaceutical industry --- Drugs --- Pharmaceutical policy --- Drug policy --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Law and legislation --- Prescribing --- Government policy --- HG 9391 Pharmaceutical Services Insurance (General Works) --- legislation and jurisprudence --- Legislation, Drug --- Europe --- Drug and Narcotic Control
Choose an application
Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.
Drugs --- Medical innovations --- Pharmaceutical industry. --- Social responsibility of business. --- Marketing --- Moral and ethical aspects. --- Research --- Social aspects. --- HD 9665.5 Pharmaceutical Industry --- pharmacie --- prijsvorming --- Ethics, Medical --- Pharmaceutical Preparations --- Drug Industry --- Varia organisaties en instellingen (GV) : Farmaceutische firma's --- Diverses organisations et institutions (SS) : Firmes pharmaceutiques --- Business --- Corporate accountability --- Corporate responsibility --- Corporate social responsibility --- Corporations --- CSR (Corporate social responsibility) --- Industries --- Social responsibility, Corporate --- Social responsibility of industry --- Business ethics --- Issues management --- Society and medical innovations --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Social responsibility --- Social aspects --- Business, Economy and Management --- Business Management --- Droit médical
Listing 1 - 2 of 2 |
Sort by
|